Methotrexate remains a valuable option for remission induction of nonsevere antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Faurschou et al
- PMID: 23203421
- DOI: 10.1002/art.37791
Methotrexate remains a valuable option for remission induction of nonsevere antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Faurschou et al
Comment in
-
Reply: To PMID 22614882.Arthritis Rheum. 2013 Mar;65(3):844. doi: 10.1002/art.37794. Arthritis Rheum. 2013. PMID: 23203542 No abstract available.
Comment on
-
Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.Arthritis Rheum. 2012 Oct;64(10):3472-7. doi: 10.1002/art.34547. Arthritis Rheum. 2012. PMID: 22614882 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
